scispace - formally typeset
Y

Yanxia Liu

Researcher at Stanford University

Publications -  29
Citations -  4371

Yanxia Liu is an academic researcher from Stanford University. The author has contributed to research in topics: CRISPR & Embryonic stem cell. The author has an hindex of 20, co-authored 25 publications receiving 3678 citations. Previous affiliations of Yanxia Liu include Peking University.

Papers
More filters
Journal ArticleDOI

Directed differentiation of human embryonic stem cells into functional hepatic cells.

TL;DR: A novel three‐stage method to efficiently direct the differentiation of human embryonic stem cells into hepatic cells in serum‐free medium is reported, which should facilitate searching the molecular mechanisms underlying human liver development, and form the basis for hepatocyte transplantation and drug tests.
Journal ArticleDOI

Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells.

TL;DR: Results show that human iPS cells, which are similar to human ES cells, can be efficiently induced to differentiate into hepatocyte-like cells.
Journal ArticleDOI

Small Molecules Enhance CRISPR Genome Editing in Pluripotent Stem Cells

TL;DR: A reporter-based screening approach for high-throughput identification of chemical compounds that can modulate precise genome editing through homology-directed repair (HDR) is developed and small molecules that can enhance CRISPR-mediated HDR efficiency are identified.
Journal ArticleDOI

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza.

TL;DR: A CRISPR-Cas13-based strategy for viral inhibition that can effectively degrade RNA from SARS-CoV-2 sequences and live influenza A virus in human lung epithelial cells is demonstrated and has the potential to become an important pan-coronavirus inhibition strategy.